Actively Recruiting

Age: 30Years +
All Genders
Healthy Volunteers
NCT03263130

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

Led by Gelb, Arthur F., M.D. · Updated on 2023-10-27

60

Participants Needed

2

Research Sites

569 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this cross-sectional, observational study is to evaluate the site and mechanism(s) for expiratory airflow limitation in chronic, treated, current or former smokers (\>15 pack years) with COPD, Emphysema, and Asthma-COPD Overlap with mild to severe expiratory airflow limitation. Treatment may include short and long acting inhaled beta2agonists, short and long acting inhaled muscarinic receptor antagonists, inhaled and or oral corticosteroid, oral antibiotic, supplemental oxygen, and PDE type 4 inhibitor. In some cases, the patient may have had a history of asthma preceding the development of COPD (Asthma COPD Overlap).

CONDITIONS

Official Title

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

Who Can Participate

Age: 30Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Asthma-COPD overlap
  • Emphysema in smokers with smoking history of more than 15 pack years
  • COPD, bronchitis, and bronchiectasis in smokers with smoking history
  • Smoking history of more than 15 pack years
Not Eligible

You will not qualify if you...

  • Non-smokers
  • Any other pulmonary diagnosis besides COPD, emphysema, or asthma-COPD overlap
  • Pulmonary fibrosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Arthur F Gelb MD

Lakewood, California, United States, 90712

Actively Recruiting

2

Arthur F Gelb MD

Lakewood, California, United States, 90712

Actively Recruiting

Loading map...

Research Team

A

Arthur F Gelb, MD

CONTACT

C

Christine Fraser

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap | DecenTrialz